Vialwirebiotech, curated
November 21, 2026, 6:52 AM
November 19, 2026
- 6:41 AM · Pharmaceutical Technology6:41 AMPfizer inks $2.6bn autoimmune deal with China’s Starna for CAR-T therapies — Pharmaceutical Technology
- 6:30 AM · STAT News
- 6:00 AM · Drug Discovery World6:00 AMSofinnova closes €725 life sciences fund — Drug Discovery World
- 4:53 AM · Pharmaceutical Technology4:53 AMGenomics, Vertex extend drug discovery alliance in $220m deal — Pharmaceutical Technology
- 3:00 AM · Labiotech (EU)3:00 AMTwo days in cell-free, three days in CHO: antibody sequence to data with Biointron’s RushDATA™ — Labiotech (EU)
November 18, 2026
- 7:20 PM · Bloomberg — Technology7:20 PMChina AI Biotech Firm Raises $200 Million in Oman-Backed Round — Bloomberg — Technology
- 11:00 AM · BioWorld11:00 AMCourt awards Gilead nearly $70M in counterfeit case — BioWorld
- 11:00 AM · BioWorld11:00 AMGSK's $10.6B Nuvalent bet pays off with Nelkarmi FDA nod — BioWorld
- 11:00 AM · BioWorld11:00 AMLoad-Beren wait: NPC drug’s long path ends with FDA nod — BioWorld
- 11:00 AM · BioWorld11:00 AMIsomorphic raises record $5B series C to scale AI drug discovery — BioWorld
- 10:36 AM · STAT News
- 9:37 AM · STAT News9:37 AMSTAT+: FDA discloses reasons for rejecting Summit drug — STAT News
- 8:59 AM · PharmaVoice8:59 AMJ&J, Novartis vet to lead Gates MRI amid TB vaccine push — PharmaVoice
- 8:00 AM · BioWorld8:00 AMIchnos Glenmark Innovation submits IND for ISB-2301 — BioWorld
- 8:00 AM · BioWorld8:00 AMADX-246 targets lung damage in rheumatoid arthritis — BioWorld
- 8:00 AM · BioWorld8:00 AMAscletis Pharma patents new STAT6 degraders — BioWorld
- 8:00 AM · BioWorld8:00 AMLaekna Pharmaceutical discloses new APLNR agonists — BioWorld
- 8:00 AM · BioWorld8:00 AMShanghai Qilu Pharmaceutical describes new Kv1.3 channel blockers — BioWorld
- 8:00 AM · BioWorld8:00 AMMarrow Therapeutics launches with focus on blood disorders — BioWorld
- 8:00 AM · BioWorld8:00 AMCorsera’s dual-targeting cardiovascular approach enters clinic — BioWorld
- 8:00 AM · BioWorld8:00 AMAvstera’s AVS-100 boosts tirzepatide weight loss in mice — BioWorld
- 8:00 AM · BioWorld8:00 AMER-300m improves liver pathology in MASH, study shows — BioWorld
- 8:00 AM · BioWorld8:00 AMDernovo Therapeutics discovers new ACC1 inhibitors — BioWorld
- 7:00 AM · Drug Discovery World7:00 AMCommit completed $60m funding round to advance lead candidate — Drug Discovery World
- 5:17 AM · Pharmaceutical Technology5:17 AMRevolution Medicines’ Rasonque gains EC authorisation for pancreatic cancer — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMFDA approves first treatment for primary membranous nephropathy — Drug Discovery World
- 4:00 AM · Drug Discovery World4:00 AMLineage acquires NeuroAirmid and Huntington’s disease programme — Drug Discovery World
- 1:00 AM · SCMP — Tech
November 17, 2026
- 7:44 PM · STAT News7:44 PMSTAT+: White House pulls nomination of Heidi Overton to lead FDA — STAT News
- 6:00 PM · SCMP — Tech
- 11:00 AM · BioWorld11:00 AMEMA calls on European Commission to re-approve Hansoh’s NSCLC drug — BioWorld
- 11:00 AM · BioWorld11:00 AMSellas soars on phase III survival endpoint in AML — BioWorld
- 11:00 AM · BioWorld11:00 AMGenepath takes Atlas newborn-screening test to market — BioWorld
- 11:00 AM · BioWorld11:00 AMSupremes deny Trump quest to reinstate grant terminations — BioWorld
- 11:00 AM · BioWorld11:00 AMLilly pledges up to $5.9B in Stipple cancer drug discovery pact — BioWorld
- 11:00 AM · BioWorld11:00 AMFDA nod takes China-origin pimicotinib into US TGCT fight — BioWorld
- 11:00 AM · BioWorld11:00 AMRoche’s oral SERD, Wilserdly, gets FDA nod in breast cancer — BioWorld
- 11:00 AM · BioWorld11:00 AMAravax's PVX-108 meets endpoints in childhood peanut allergy — BioWorld
- 9:56 AM · Pharmaceutical Executive9:56 AM<![CDATA[Gilead Signs Royalty-Free Licensing Deals to Broaden Access to Obeldesivir ]]> — Pharmaceutical Executive
- 9:26 AM · TechCrunch9:26 AMScience Corporation’s brain tech is worth $3.5 billion after new funding — TechCrunch
- 8:27 AM · STAT News8:27 AMNIH’s infectious disease unit has a new head at last — STAT News
- 8:00 AM · BioWorld8:00 AMRegulatory: Hutchmed anemia drug gets orphan designation — BioWorld
- 8:00 AM · BioWorld8:00 AMGlycoera advances GE-8820 into clinic for autoimmune diseases — BioWorld
- 8:00 AM · BioWorld8:00 AMHenlius gains clinical trial clearance in China for HLX-105 — BioWorld
- 8:00 AM · BioWorld8:00 AMCancer Research UK and Dewpoint collaborate on DPTX-8743 — BioWorld
- 8:00 AM · BioWorld8:00 AMRakuten Medical’s photoimmunotherapy moves into phase I — BioWorld
- 8:00 AM · BioWorld8:00 AMNMPA clears Simcere’s SIM-0712 for clinic in atopic dermatitis — BioWorld
- 7:06 AM · Drug Discovery World7:06 AMMOGRIFY-derived transcription factors preserve functional vision — Drug Discovery World